Matt Wallach

Matt Wallach is co-founder and president of Veeva. Since the company’s launch in 2007, he has helped build Veeva into one of the most valued and trusted partners to the world’s largest pharmaceutical companies and emerging biotechs. With almost 20 years of life sciences expertise, he plays a pivotal role in helping meet customers’ most pressing global requirements in developing and bringing products to market.

Prior to starting Veeva, Matt held leadership positions in product management, marketing, and business development at various healthcare technology companies. Earlier in his career, Matt was the general manager of the pharmaceuticals & biotechnology division at Siebel Systems, where he established the company as the market leader in Pharma CRM and clinical trial management systems (CTMS) before its acquisition by Oracle.

Matt serves on the board of directors of HealthVerity and advisory board at Crossix, two innovators in healthcare data and analytics. He received an MBA from Harvard Business School and a bachelor of science degree in economics from Yale University.